Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics
During production of therapeutic monoclonal antibodies (mAbs) in mammalian cell culture, it is important to ensure that viral impurities and potential viral contaminants will be removed during downstream purification. Anion exchange chromatography provides a high degree of virus removal from mAb fee...
Gespeichert in:
Veröffentlicht in: | Biotechnology and bioengineering 2009-10, Vol.104 (2), p.371-380 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 380 |
---|---|
container_issue | 2 |
container_start_page | 371 |
container_title | Biotechnology and bioengineering |
container_volume | 104 |
creator | Strauss, Daniel M Lute, Scott Tebaykina, Zinaida Frey, Douglas D Ho, Cintia Blank, Gregory S Brorson, Kurt Chen, Qi Yang, Bin |
description | During production of therapeutic monoclonal antibodies (mAbs) in mammalian cell culture, it is important to ensure that viral impurities and potential viral contaminants will be removed during downstream purification. Anion exchange chromatography provides a high degree of virus removal from mAb feedstocks, but the mechanism by which this is achieved has not been characterized. In this work, we have investigated the binding of three viruses to Q sepharose fast flow (QSFF) resin to determine the degree to which electrostatic interactions are responsible for viral clearance by this process. We first used a chromatofocusing technique to determine the isoelectric points of the viruses and established that they are negatively charged under standard QSFF conditions. We then determined that virus removal by this chromatography resin is strongly disrupted by the presence of high salt concentrations or by the absence of the positively charged Q ligand, indicating that binding of the virus to the resin is primarily due to electrostatic forces, and that any non-electrostatic interactions which may be present are not sufficient to provide virus removal. Finally, we determined the binding profile of a virus in a QSFF column after a viral clearance process. These data indicate that virus particles generally behave similarly to proteins, but they also illustrate the high degree of performance necessary to achieve several logs of virus reduction. Overall, this mechanistic understanding of an important viral clearance process provides the foundation for the development of science-based process validation strategies to ensure viral safety of biotechnology products. Biotechnol. Bioeng. 2009; 104: 371-380 |
doi_str_mv | 10.1002/bit.22416 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67610269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>35002389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5046-f82b5377e80ea11daabffd7f9d26d19fecaebfdfe39658c027090ae74de086f63</originalsourceid><addsrcrecordid>eNqF0d1u0zAUB_AIgVgZXPACYCGBxEU2fyR2fDkq9oGmTYh1XFpOfNx6JHGxk46-BY-Mu3ZDQkK7si39zjm2_1n2muADgjE9rN1wQGlB-JNsQrAUOaYSP80mGGOes1LSvexFjDfpKCrOn2d7RJaiLEgxyX7PegMhDro3rp-jYQGog2ahexc75C1auTBGFKDzK92ieo2-ogjLhQ4-ArI6Dsi2_hY1i-A7Pfh50MvFGpkx3Hdbpq11jR6c7zcNp6eXeQNti9JYtwKDaueTS3UwDq6JL7NnVrcRXu3W_Wx2_PlqepqfX56cTY_O86bEBc9tReuSCQEVBk2I0bq21ggrDeWGSAuNhtoaC0zysmowFVhiDaIwgCtuOdvPPmz7LoP_OUIcVOfi5mK6Bz9GxQUnmHL5KGRlioBVj0NKsCgZJQm--wfe-DH06bXJsDS3kBv0cYua9NUxgFXL4Dod1opgtUldpdTVXerJvtk1HOsOzF-5izmB9zugY6NbG3TfuPjgKJGYiLsnHG7drWth_f-J6tPZ1f3ofFvh4gC_Hip0-JF-kIlSfb84UdfTY3pBp9fqS_Jvt95qr_Q8pFvMvlFMGCZcFLii7A8ONd5I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213761491</pqid></control><display><type>article</type><title>Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Strauss, Daniel M ; Lute, Scott ; Tebaykina, Zinaida ; Frey, Douglas D ; Ho, Cintia ; Blank, Gregory S ; Brorson, Kurt ; Chen, Qi ; Yang, Bin</creator><creatorcontrib>Strauss, Daniel M ; Lute, Scott ; Tebaykina, Zinaida ; Frey, Douglas D ; Ho, Cintia ; Blank, Gregory S ; Brorson, Kurt ; Chen, Qi ; Yang, Bin</creatorcontrib><description>During production of therapeutic monoclonal antibodies (mAbs) in mammalian cell culture, it is important to ensure that viral impurities and potential viral contaminants will be removed during downstream purification. Anion exchange chromatography provides a high degree of virus removal from mAb feedstocks, but the mechanism by which this is achieved has not been characterized. In this work, we have investigated the binding of three viruses to Q sepharose fast flow (QSFF) resin to determine the degree to which electrostatic interactions are responsible for viral clearance by this process. We first used a chromatofocusing technique to determine the isoelectric points of the viruses and established that they are negatively charged under standard QSFF conditions. We then determined that virus removal by this chromatography resin is strongly disrupted by the presence of high salt concentrations or by the absence of the positively charged Q ligand, indicating that binding of the virus to the resin is primarily due to electrostatic forces, and that any non-electrostatic interactions which may be present are not sufficient to provide virus removal. Finally, we determined the binding profile of a virus in a QSFF column after a viral clearance process. These data indicate that virus particles generally behave similarly to proteins, but they also illustrate the high degree of performance necessary to achieve several logs of virus reduction. Overall, this mechanistic understanding of an important viral clearance process provides the foundation for the development of science-based process validation strategies to ensure viral safety of biotechnology products. Biotechnol. Bioeng. 2009; 104: 371-380</description><identifier>ISSN: 0006-3592</identifier><identifier>EISSN: 1097-0290</identifier><identifier>DOI: 10.1002/bit.22416</identifier><identifier>PMID: 19575414</identifier><identifier>CODEN: BIBIAU</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; anion exchange chromatography (AEX) ; Antibodies, Monoclonal - isolation & purification ; Antibodies, Monoclonal - metabolism ; Biological and medical sciences ; Biotechnology ; Cell culture ; CHO Cells ; chromatofocusing ; Chromatography, Agarose - methods ; Cricetinae ; Cricetulus ; Culture Media - chemistry ; Fundamental and applied biological sciences. Psychology ; Ion chromatography ; Ion exchange ; Monoclonal antibodies ; Q sepharose fast flow (QSFF) ; Tissue engineering ; viral clearance ; Virus Attachment ; virus chromatography ; Viruses ; Viruses - isolation & purification</subject><ispartof>Biotechnology and bioengineering, 2009-10, Vol.104 (2), p.371-380</ispartof><rights>Copyright © 2009 Wiley Periodicals, Inc.</rights><rights>2009 INIST-CNRS</rights><rights>(c) 2009 Wiley Periodicals, Inc.</rights><rights>Copyright John Wiley and Sons, Limited Oct 1, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5046-f82b5377e80ea11daabffd7f9d26d19fecaebfdfe39658c027090ae74de086f63</citedby><cites>FETCH-LOGICAL-c5046-f82b5377e80ea11daabffd7f9d26d19fecaebfdfe39658c027090ae74de086f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbit.22416$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbit.22416$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21901789$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19575414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Strauss, Daniel M</creatorcontrib><creatorcontrib>Lute, Scott</creatorcontrib><creatorcontrib>Tebaykina, Zinaida</creatorcontrib><creatorcontrib>Frey, Douglas D</creatorcontrib><creatorcontrib>Ho, Cintia</creatorcontrib><creatorcontrib>Blank, Gregory S</creatorcontrib><creatorcontrib>Brorson, Kurt</creatorcontrib><creatorcontrib>Chen, Qi</creatorcontrib><creatorcontrib>Yang, Bin</creatorcontrib><title>Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics</title><title>Biotechnology and bioengineering</title><addtitle>Biotechnol. Bioeng</addtitle><description>During production of therapeutic monoclonal antibodies (mAbs) in mammalian cell culture, it is important to ensure that viral impurities and potential viral contaminants will be removed during downstream purification. Anion exchange chromatography provides a high degree of virus removal from mAb feedstocks, but the mechanism by which this is achieved has not been characterized. In this work, we have investigated the binding of three viruses to Q sepharose fast flow (QSFF) resin to determine the degree to which electrostatic interactions are responsible for viral clearance by this process. We first used a chromatofocusing technique to determine the isoelectric points of the viruses and established that they are negatively charged under standard QSFF conditions. We then determined that virus removal by this chromatography resin is strongly disrupted by the presence of high salt concentrations or by the absence of the positively charged Q ligand, indicating that binding of the virus to the resin is primarily due to electrostatic forces, and that any non-electrostatic interactions which may be present are not sufficient to provide virus removal. Finally, we determined the binding profile of a virus in a QSFF column after a viral clearance process. These data indicate that virus particles generally behave similarly to proteins, but they also illustrate the high degree of performance necessary to achieve several logs of virus reduction. Overall, this mechanistic understanding of an important viral clearance process provides the foundation for the development of science-based process validation strategies to ensure viral safety of biotechnology products. Biotechnol. Bioeng. 2009; 104: 371-380</description><subject>Animals</subject><subject>anion exchange chromatography (AEX)</subject><subject>Antibodies, Monoclonal - isolation & purification</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Cell culture</subject><subject>CHO Cells</subject><subject>chromatofocusing</subject><subject>Chromatography, Agarose - methods</subject><subject>Cricetinae</subject><subject>Cricetulus</subject><subject>Culture Media - chemistry</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ion chromatography</subject><subject>Ion exchange</subject><subject>Monoclonal antibodies</subject><subject>Q sepharose fast flow (QSFF)</subject><subject>Tissue engineering</subject><subject>viral clearance</subject><subject>Virus Attachment</subject><subject>virus chromatography</subject><subject>Viruses</subject><subject>Viruses - isolation & purification</subject><issn>0006-3592</issn><issn>1097-0290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0d1u0zAUB_AIgVgZXPACYCGBxEU2fyR2fDkq9oGmTYh1XFpOfNx6JHGxk46-BY-Mu3ZDQkK7si39zjm2_1n2muADgjE9rN1wQGlB-JNsQrAUOaYSP80mGGOes1LSvexFjDfpKCrOn2d7RJaiLEgxyX7PegMhDro3rp-jYQGog2ahexc75C1auTBGFKDzK92ieo2-ogjLhQ4-ArI6Dsi2_hY1i-A7Pfh50MvFGpkx3Hdbpq11jR6c7zcNp6eXeQNti9JYtwKDaueTS3UwDq6JL7NnVrcRXu3W_Wx2_PlqepqfX56cTY_O86bEBc9tReuSCQEVBk2I0bq21ggrDeWGSAuNhtoaC0zysmowFVhiDaIwgCtuOdvPPmz7LoP_OUIcVOfi5mK6Bz9GxQUnmHL5KGRlioBVj0NKsCgZJQm--wfe-DH06bXJsDS3kBv0cYua9NUxgFXL4Dod1opgtUldpdTVXerJvtk1HOsOzF-5izmB9zugY6NbG3TfuPjgKJGYiLsnHG7drWth_f-J6tPZ1f3ofFvh4gC_Hip0-JF-kIlSfb84UdfTY3pBp9fqS_Jvt95qr_Q8pFvMvlFMGCZcFLii7A8ONd5I</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Strauss, Daniel M</creator><creator>Lute, Scott</creator><creator>Tebaykina, Zinaida</creator><creator>Frey, Douglas D</creator><creator>Ho, Cintia</creator><creator>Blank, Gregory S</creator><creator>Brorson, Kurt</creator><creator>Chen, Qi</creator><creator>Yang, Bin</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>FBQ</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20091001</creationdate><title>Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics</title><author>Strauss, Daniel M ; Lute, Scott ; Tebaykina, Zinaida ; Frey, Douglas D ; Ho, Cintia ; Blank, Gregory S ; Brorson, Kurt ; Chen, Qi ; Yang, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5046-f82b5377e80ea11daabffd7f9d26d19fecaebfdfe39658c027090ae74de086f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>anion exchange chromatography (AEX)</topic><topic>Antibodies, Monoclonal - isolation & purification</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Cell culture</topic><topic>CHO Cells</topic><topic>chromatofocusing</topic><topic>Chromatography, Agarose - methods</topic><topic>Cricetinae</topic><topic>Cricetulus</topic><topic>Culture Media - chemistry</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ion chromatography</topic><topic>Ion exchange</topic><topic>Monoclonal antibodies</topic><topic>Q sepharose fast flow (QSFF)</topic><topic>Tissue engineering</topic><topic>viral clearance</topic><topic>Virus Attachment</topic><topic>virus chromatography</topic><topic>Viruses</topic><topic>Viruses - isolation & purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Strauss, Daniel M</creatorcontrib><creatorcontrib>Lute, Scott</creatorcontrib><creatorcontrib>Tebaykina, Zinaida</creatorcontrib><creatorcontrib>Frey, Douglas D</creatorcontrib><creatorcontrib>Ho, Cintia</creatorcontrib><creatorcontrib>Blank, Gregory S</creatorcontrib><creatorcontrib>Brorson, Kurt</creatorcontrib><creatorcontrib>Chen, Qi</creatorcontrib><creatorcontrib>Yang, Bin</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and bioengineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Strauss, Daniel M</au><au>Lute, Scott</au><au>Tebaykina, Zinaida</au><au>Frey, Douglas D</au><au>Ho, Cintia</au><au>Blank, Gregory S</au><au>Brorson, Kurt</au><au>Chen, Qi</au><au>Yang, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics</atitle><jtitle>Biotechnology and bioengineering</jtitle><addtitle>Biotechnol. Bioeng</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>104</volume><issue>2</issue><spage>371</spage><epage>380</epage><pages>371-380</pages><issn>0006-3592</issn><eissn>1097-0290</eissn><coden>BIBIAU</coden><abstract>During production of therapeutic monoclonal antibodies (mAbs) in mammalian cell culture, it is important to ensure that viral impurities and potential viral contaminants will be removed during downstream purification. Anion exchange chromatography provides a high degree of virus removal from mAb feedstocks, but the mechanism by which this is achieved has not been characterized. In this work, we have investigated the binding of three viruses to Q sepharose fast flow (QSFF) resin to determine the degree to which electrostatic interactions are responsible for viral clearance by this process. We first used a chromatofocusing technique to determine the isoelectric points of the viruses and established that they are negatively charged under standard QSFF conditions. We then determined that virus removal by this chromatography resin is strongly disrupted by the presence of high salt concentrations or by the absence of the positively charged Q ligand, indicating that binding of the virus to the resin is primarily due to electrostatic forces, and that any non-electrostatic interactions which may be present are not sufficient to provide virus removal. Finally, we determined the binding profile of a virus in a QSFF column after a viral clearance process. These data indicate that virus particles generally behave similarly to proteins, but they also illustrate the high degree of performance necessary to achieve several logs of virus reduction. Overall, this mechanistic understanding of an important viral clearance process provides the foundation for the development of science-based process validation strategies to ensure viral safety of biotechnology products. Biotechnol. Bioeng. 2009; 104: 371-380</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>19575414</pmid><doi>10.1002/bit.22416</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-3592 |
ispartof | Biotechnology and bioengineering, 2009-10, Vol.104 (2), p.371-380 |
issn | 0006-3592 1097-0290 |
language | eng |
recordid | cdi_proquest_miscellaneous_67610269 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Animals anion exchange chromatography (AEX) Antibodies, Monoclonal - isolation & purification Antibodies, Monoclonal - metabolism Biological and medical sciences Biotechnology Cell culture CHO Cells chromatofocusing Chromatography, Agarose - methods Cricetinae Cricetulus Culture Media - chemistry Fundamental and applied biological sciences. Psychology Ion chromatography Ion exchange Monoclonal antibodies Q sepharose fast flow (QSFF) Tissue engineering viral clearance Virus Attachment virus chromatography Viruses Viruses - isolation & purification |
title | Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A13%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20the%20mechanism%20of%20virus%20removal%20by%20Q%20sepharose%20fast%20flow%20chromatography%20during%20the%20purification%20of%20CHO-cell%20derived%20biotherapeutics&rft.jtitle=Biotechnology%20and%20bioengineering&rft.au=Strauss,%20Daniel%20M&rft.date=2009-10-01&rft.volume=104&rft.issue=2&rft.spage=371&rft.epage=380&rft.pages=371-380&rft.issn=0006-3592&rft.eissn=1097-0290&rft.coden=BIBIAU&rft_id=info:doi/10.1002/bit.22416&rft_dat=%3Cproquest_cross%3E35002389%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213761491&rft_id=info:pmid/19575414&rfr_iscdi=true |